AWM
NVO

Apollon Wealth Management’s Novo Nordisk NVO Stock Holding History

Apollon Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.06M Sell
56,015
-4,815
-8% -$228K 0.03% 375
2025
Q4 		$3.1M Buy
60,830
+6,093
+11% +$312K 0.05% 289
2025
Q3 		$3.04M Buy
54,737
+8,159
+18% +$478K 0.05% 288
2025
Q2 		$3.21M Sell
46,578
-2,614
-5% -$178K 0.06% 257
2025
Q1 		$3.42M Buy
49,192
+4,964
+11% +$410K 0.08% 237
2024
Q4 		$3.8M Buy
44,228
+5,393
+14% +$583K 0.09% 206
2024
Q3 		$4.62M Buy
38,835
+906
+2% +$121K 0.13% 138
2024
Q2 		$5.41M Sell
37,929
-649
-2% -$86K 0.16% 112
2024
Q1 		$4.95M Sell
38,578
-2,577
-6% -$307K 0.16% 119
2023
Q4 		$4.26M Buy
41,155
+25,179
+158% +$2.49M 0.15% 135
2023
Q3 		$1.45M Buy
15,976
+2,508
+19% +$221K 0.07% 268
2023
Q2 		$1.09M Buy
13,468
+562
+4% +$45.9K 0.05% 364
2023
Q1 		$1.03M Sell
12,906
-566
-4% -$40.1K 0.06% 321
2022
Q4 		$912K Sell
13,472
-340
-2% -$19.9K 0.06% 331
2022
Q3 		$688K Buy
13,812
+2,080
+18% +$111K 0.06% 361
2022
Q2 		$654K Buy
11,732
+1,062
+10% +$58.9K 0.05% 365
2022
Q1 		$592K Buy
10,670
+3,224
+43% +$165K 0.04% 419
2021
Q4 		$417K Buy
+7,446
New +$403K 0.03% 502
2021
Q1 		– Sell
-27,274
Closed -$953K – 362
2020
Q4 		$953K Buy
+27,274
New +$943K 0.26% 83
2020
Q3 		– Sell
-62
Closed -$2K – 513
2020
Q2 		$2K Buy
+62
New +$1.98K ﹤0.01% 644

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Apollon Wealth Management's NVO Position: Q1 2026 in Review

Apollon Wealth Management reduced its Novo Nordisk (NVO) stake by 7.9% in Q1 2026, selling an estimated $228K and leaving 56,015 shares worth $2.06M. The position accounts for 0.03% of the portfolio, ranked #375.

Apollon Wealth Management first reported a position in NVO in Q2 2020 and has held it in 20 quarters since. The position peaked at $5.41M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Apollon Wealth Management held 56,015 shares of Novo Nordisk worth $2.06M as of Q1 2026.
  • Apollon Wealth Management sold 4,815 Novo Nordisk shares in Q1 2026, an estimated $228K.
  • Novo Nordisk made up 0.03% of Apollon Wealth Management's portfolio in Q1 2026, its #375 holding.
  • Apollon Wealth Management first reported a position in Novo Nordisk in Q2 2020 and has held it in 20 quarters since.
  • Apollon Wealth Management's Novo Nordisk position peaked at $5.41M in Q2 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Apollon Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.